Sandrine Flory
Director/Board Member chez TRANSGENE
Profil
Sandrine Flory is currently a Director at Transgene SA, TSGH SAS, GeNeuro SA (Switzerland), and Institut Mérieux SA. She previously worked as the Chief Financial Officer-EMEA Division at bioMérieux SA. Ms. Flory holds a graduate degree from Universite Lumiere Lyon 2.
Postes actifs de Sandrine Flory
| Sociétés | Poste | Début |
|---|---|---|
| TRANSGENE | Director/Board Member | 01/01/2021 |
| GENEURO SA | Director/Board Member | 18/03/2024 |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Director of Finance/CFO | 01/01/2020 |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Director/Board Member | 01/01/2002 |
Anciens postes connus de Sandrine Flory
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMÉRIEUX | Corporate Officer/Principal | 01/01/2020 |
Formation de Sandrine Flory
| Universite Lumiere Lyon 2 | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TRANSGENE | Health Technology |
| BIOMÉRIEUX | Health Technology |
| GENEURO SA | Health Technology |
| Entreprise privées | 2 |
|---|---|
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
